The receiver operating characteristic (ROC) curve analysis for ORC6 expression yielded an area under the curve (AUC) of 0.916, suggesting that ORC6 overexpression can be a robust biomarker for diagnosing between normal and glioma tissues (Fig. 1G). Here, ORC6 is linked to central nervous system cancer.